iCardio.ai key facts
as of Oct 2026- Developer of deep-learning echo tools designed for echocardiographic analysis.
- iCardio.ai is valued at approximately $330K as of Oct 2026 (last reported valuation).
- It has raised $1.4M; the latest was Later Stage VC in Apr 2026.
- Notable investors include Techstars, CONNECT (San Diego), The Roddenberry Foundation, BSD Enterprises, BeyondBio (Isarel) — 13 tracked in total.
- Status: Privately Held (backing).
iCardio.ai's last reported valuation, May 2023. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch iCardio.ai: the Monday email on marks, rounds and moves
iCardio.ai funding rounds
No funding rounds for iCardio.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs iCardio.ai
13+iCardio.ai valuation
iCardio.ai's last reported valuation was $330,000 in May 2023. No priced round, secondary trade or fund mark has surfaced since.
iCardio.ai investors
13 investors are on record for iCardio.ai, including Techstars, CONNECT (San Diego), The Roddenberry Foundation and BSD Enterprises.
About iCardio.ai
Developer of deep-learning echo tools designed for echocardiographic analysis. The company's models are based on segmentation, classification, regression analysis, and artificial intelligence for the interpretation of ultrasound imaging, with a focus on echocardiograms, enabling ultrasound companies to research and development of AI algorithms and offering a custom application for the interpretation of ultrasound imaging.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2018
- Employees
- 20
- Website
- icardio.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.